Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome

Christopher Raske, Paul J Hagerman

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome is a late adult onset neurodegenerative disorder that affects individuals who carry a premutation CGG repeat expansion (55-200 CGG repeats) in the 5′ untranslated portion of the fragile X mental retardation 1 (FMR1) gene. Affected individuals display cognitive decline, progressive intention tremor, gait ataxia, neuropathy, psychiatric symptoms, and parkinsonism; the severity of both clinical and neuropathological phenotypes is positively correlated with the extent of the CGG expansion. Overexpression of the expanded CGG repeat messenger RNA results in a direct gain-of-function cellular toxicity that is believed to form the pathogenic basis for fragile X-associated tremor/ataxia syndrome. This mechanism is entirely different from the mechanism giving rise to fragile X syndrome, which is due to transcriptional silencing and consequent loss of FMR1 protein. Much of the research in the field has focused on understanding the link between the pathogenic FMR1 messenger RNA and the potential proteins that interact with it.

Original languageEnglish (US)
Pages (from-to)825-829
Number of pages5
JournalJournal of Investigative Medicine
Volume57
Issue number8
DOIs
StatePublished - Dec 2009

Fingerprint

Intellectual Disability
Fragile X Mental Retardation Protein
Gait Ataxia
Fragile X Syndrome
Messenger RNA
Parkinsonian Disorders
Tremor
Neurodegenerative Diseases
Psychiatry
Toxicity
Genes
Phenotype
Research
Proteins
Fragile X Tremor Ataxia Syndrome
Cognitive Dysfunction

Keywords

  • Autism
  • CGG
  • Fragile X
  • Neurodegeneration
  • Neuropathy
  • Trinucleotide

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome. / Raske, Christopher; Hagerman, Paul J.

In: Journal of Investigative Medicine, Vol. 57, No. 8, 12.2009, p. 825-829.

Research output: Contribution to journalArticle

@article{660f44a6cdcb442980e2bbcf26f417d7,
title = "Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome",
abstract = "Fragile X-associated tremor/ataxia syndrome is a late adult onset neurodegenerative disorder that affects individuals who carry a premutation CGG repeat expansion (55-200 CGG repeats) in the 5′ untranslated portion of the fragile X mental retardation 1 (FMR1) gene. Affected individuals display cognitive decline, progressive intention tremor, gait ataxia, neuropathy, psychiatric symptoms, and parkinsonism; the severity of both clinical and neuropathological phenotypes is positively correlated with the extent of the CGG expansion. Overexpression of the expanded CGG repeat messenger RNA results in a direct gain-of-function cellular toxicity that is believed to form the pathogenic basis for fragile X-associated tremor/ataxia syndrome. This mechanism is entirely different from the mechanism giving rise to fragile X syndrome, which is due to transcriptional silencing and consequent loss of FMR1 protein. Much of the research in the field has focused on understanding the link between the pathogenic FMR1 messenger RNA and the potential proteins that interact with it.",
keywords = "Autism, CGG, Fragile X, Neurodegeneration, Neuropathy, Trinucleotide",
author = "Christopher Raske and Hagerman, {Paul J}",
year = "2009",
month = "12",
doi = "10.231/JIM.0b013e3181be329a",
language = "English (US)",
volume = "57",
pages = "825--829",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome

AU - Raske, Christopher

AU - Hagerman, Paul J

PY - 2009/12

Y1 - 2009/12

N2 - Fragile X-associated tremor/ataxia syndrome is a late adult onset neurodegenerative disorder that affects individuals who carry a premutation CGG repeat expansion (55-200 CGG repeats) in the 5′ untranslated portion of the fragile X mental retardation 1 (FMR1) gene. Affected individuals display cognitive decline, progressive intention tremor, gait ataxia, neuropathy, psychiatric symptoms, and parkinsonism; the severity of both clinical and neuropathological phenotypes is positively correlated with the extent of the CGG expansion. Overexpression of the expanded CGG repeat messenger RNA results in a direct gain-of-function cellular toxicity that is believed to form the pathogenic basis for fragile X-associated tremor/ataxia syndrome. This mechanism is entirely different from the mechanism giving rise to fragile X syndrome, which is due to transcriptional silencing and consequent loss of FMR1 protein. Much of the research in the field has focused on understanding the link between the pathogenic FMR1 messenger RNA and the potential proteins that interact with it.

AB - Fragile X-associated tremor/ataxia syndrome is a late adult onset neurodegenerative disorder that affects individuals who carry a premutation CGG repeat expansion (55-200 CGG repeats) in the 5′ untranslated portion of the fragile X mental retardation 1 (FMR1) gene. Affected individuals display cognitive decline, progressive intention tremor, gait ataxia, neuropathy, psychiatric symptoms, and parkinsonism; the severity of both clinical and neuropathological phenotypes is positively correlated with the extent of the CGG expansion. Overexpression of the expanded CGG repeat messenger RNA results in a direct gain-of-function cellular toxicity that is believed to form the pathogenic basis for fragile X-associated tremor/ataxia syndrome. This mechanism is entirely different from the mechanism giving rise to fragile X syndrome, which is due to transcriptional silencing and consequent loss of FMR1 protein. Much of the research in the field has focused on understanding the link between the pathogenic FMR1 messenger RNA and the potential proteins that interact with it.

KW - Autism

KW - CGG

KW - Fragile X

KW - Neurodegeneration

KW - Neuropathy

KW - Trinucleotide

UR - http://www.scopus.com/inward/record.url?scp=74249089729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74249089729&partnerID=8YFLogxK

U2 - 10.231/JIM.0b013e3181be329a

DO - 10.231/JIM.0b013e3181be329a

M3 - Article

VL - 57

SP - 825

EP - 829

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 8

ER -